SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-403654
Filing Date
2014-11-07
Accepted
2014-11-07 17:13:27
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d818185d10q.htm 10-Q 196621
2 EX-31.1 d818185dex311.htm EX-31.1 7166
3 EX-31.2 d818185dex312.htm EX-31.2 7194
4 EX-32.1 d818185dex321.htm EX-32.1 7266
  Complete submission text file 0001193125-14-403654.txt   2945095

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT qhoi-20140930.xml EX-101.INS 224514
6 XBRL TAXONOMY EXTENSION SCHEMA qhoi-20140930.xsd EX-101.SCH 54636
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qhoi-20140930_cal.xml EX-101.CAL 31546
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qhoi-20140930_def.xml EX-101.DEF 89131
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE qhoi-20140930_lab.xml EX-101.LAB 636539
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qhoi-20140930_pre.xml EX-101.PRE 211343
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52062 | Film No.: 141205840
SIC: 2834 Pharmaceutical Preparations